Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LASMIDITAN vs LATANOPROST\TIMOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LASMIDITAN vs LATANOPROST\TIMOLOL: Safety Overview

Metric LASMIDITAN LATANOPROST\TIMOLOL
Total FAERS Reports 927 195
Deaths Reported 12 23
Death Rate 1.3% 11.8%
Hospitalizations 23 42
Average Patient Age 47.0 yrs 62.8 yrs
% Female Patients 85.4% 83.7%
FDA Approval Date Dec 18, 2020 N/A
Manufacturer Eli Lilly and Company N/A
Route ORAL N/A
Marketing Status Prescription N/A